KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:IPXL
Delisted

Impax Laboratories Fund Forecast

$18.30
+0 (+0%)
At Close: May 11, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Impax Laboratories fund price ended at $18.30 on Friday, after losing 0%.
(Updated on May 11, 2018)

Sell candidate since May 03, 2018 PDF

No changes to the price of Impax Laboratories fund on the last trading day (Friday, 11th May 2018). During the last trading day the fund fluctuated 0% from a day low at $18.30 to a day high of $18.30. The price has been going up and down for this period, and there has been a -3.68% loss for the last 2 weeks.

The fund lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the fund is expected to fall -6.29% during the next 3 months and, with a 90% probability hold a price between $16.42 and $18.93 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IPXL Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, May 03, 2018, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Impax Laboratories fund holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $18.30 and $19.09. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation

Support, Risk & Stop-loss for Impax Laboratories fund

There is no support from accumulated volume below today's level and given the right condition the fund may perform very badly in the next couple of days.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IPXL) For The Upcoming Trading Day Of Monday 14th

For the upcoming trading day on Monday, 14th we expect Impax Laboratories to open at $18.30, and during the day (based on 14 day Average True Range), to move between $17.63 and $18.97, which gives a possible trading interval of +/-$0.665 (+/-3.64%) up or down from last closing price. If Impax Laboratories takes out the full calculated possible swing range there will be an estimated 7.27% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $19.45, some $1.15 (6.28%) from the current price of $18.30, our system finds the risk reward not very attractive.

Is Impax Laboratories fund A Buy?

Impax Laboratories holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this fund.

Current score: -1.950 Sell Candidate Unchanged

Predicted Opening Price for Impax Laboratories of Monday, May 14, 2018

Fair opening price May 14, 2018 Current price
$18.30 ( 0%) $18.30

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IPXL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.30 .
R2 18.30 .
R1 18.30 .
Current price: 18.30
Support S1 18.30 .
S2 18.30 .
S3 18.30 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 20.20 10.38 %
R2 19.70 7.65 %
R1 19.45 6.28 %
Current price 18.30
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Impax Laboratories Fund and on which exchange is it traded?
The symbol for Impax Laboratories is IPXL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Impax Laboratories Fund?
Impax Laboratories holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this fund.

How to buy Impax Laboratories Fund?
Impax Laboratories Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Impax Laboratories Fund.

What's the current price of Impax Laboratories Fund?
As of the end of day on the May 11, 2018, the price of an Impax Laboratories (IPXL) share was $18.30.

What is the 52-week high and low for Impax Laboratories Fund?
The 52-week high for Impax Laboratories Fund is $25.70 and the 52-week low is $13.25.
Click to get the best stock tips daily for free!

About Impax Laboratories

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Impax Generics and Impax Specialty Pharma. The Impax Generics segment provides generic pharmaceutical products directly to wholesalers, large retail drug chains, and others; generic prescription products through third-party pharmaceutical entities pursuant to alliance and collaborati... IPXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT